Your browser is no longer supported. Please, upgrade your browser.
Settings
TTOO T2 Biosystems, Inc. daily Stock Chart
TTOO [NASD]
T2 Biosystems, Inc.
Index- P/E- EPS (ttm)-1.64 Insider Own2.30% Shs Outstand46.16M Perf Week-7.78%
Market Cap218.80M Forward P/E- EPS next Y-1.13 Insider Trans-15.77% Shs Float29.23M Perf Month-23.92%
Income-57.50M PEG- EPS next Q-0.33 Inst Own72.60% Short Float11.46% Perf Quarter-27.96%
Sales9.00M P/S24.31 EPS this Y7.80% Inst Trans0.12% Short Ratio5.54 Perf Half Y-31.80%
Book/sh0.84 P/B5.64 EPS next Y15.70% ROA-91.70% Target Price12.50 Perf Year16.46%
Cash/sh1.53 P/C3.09 EPS next 5Y- ROE-556.10% 52W Range3.60 - 9.98 Perf YTD15.05%
Dividend- P/FCF- EPS past 5Y-13.20% ROI-125.20% 52W High-52.51% Beta1.44
Dividend %- Quick Ratio7.10 Sales past 5Y200.60% Gross Margin-68.10% 52W Low31.56% ATR0.43
Employees161 Current Ratio7.30 Sales Q/Q290.00% Oper. Margin- RSI (14)28.82 Volatility7.28% 7.75%
OptionableYes Debt/Eq1.32 EPS Q/Q36.10% Profit Margin- Rel Volume1.52 Prev Close5.00
ShortableYes LT Debt/Eq1.20 EarningsNov 01 AMC Payout- Avg Volume604.32K Price4.74
Recom1.60 SMA20-22.36% SMA50-24.69% SMA200-27.13% Volume920,958 Change-5.20%
Jun-01-18Upgrade Leerink Partners Mkt Perform → Outperform
May-30-18Reiterated H.C. Wainwright Buy $8.50 → $14
May-29-18Reiterated WBB Securities Strong Buy $12 → $20
Mar-29-18Reiterated H.C. Wainwright Buy $8 → $8.50
Jan-29-18Initiated Goldman Neutral $5.20
Oct-18-17Initiated H.C. Wainwright Buy $8
Mar-15-17Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-10-16Resumed Leerink Partners Mkt Perform $5
Nov-02-16Reiterated Cantor Fitzgerald Buy $10 → $9
Jul-20-16Upgrade WBB Securities Buy → Strong Buy $11 → $12
Jun-22-16Upgrade WBB Securities Speculative Buy → Buy $11
Apr-12-16Reiterated Canaccord Genuity Buy $13 → $12
Feb-17-16Initiated WBB Securities Speculative Buy $11
Feb-10-16Initiated Cantor Fitzgerald Buy $15
Oct-18-18 07:00AM  T2 Biosystems Announces 2018 Third Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Oct-05-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Oct-03-18 07:00AM  T2 Biosystems Announces Customer Presentations at October Conferences GlobeNewswire
Sep-26-18 04:56PM  Here's Why T2 Biosystems Rose as Much as 16% Today Motley Fool +9.69%
07:00AM  New Data Suggests T2 Biosystems T2Lyme Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease GlobeNewswire
Sep-10-18 07:00AM  T2 Biosystems to Participate in Two Upcoming Investor Conferences GlobeNewswire
Sep-07-18 01:33PM  Should T2 Biosystems Incs (NASDAQ:TTOO) Recent Earnings Worry You? Simply Wall St. +5.64%
07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Aug-13-18 11:40PM  Edited Transcript of TTOO earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-06-18 07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire +13.81%
Aug-02-18 05:39PM  T2 Biosystems: 2Q Earnings Snapshot Associated Press
04:01PM  T2 Biosystems Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Jul-24-18 07:00AM  T2 Biosystems to Participate in Two Upcoming Conferences GlobeNewswire -6.99%
Jul-20-18 07:00AM  T2 Biosystems Announces 2018 Second Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Jul-09-18 04:15PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-29-18 07:05AM  Free Stock Performance Review on Thermo Fisher Scientific and Three Additional Medical Research Stocks ACCESSWIRE
Jun-25-18 07:00AM  T2 Biosystems Added to the Russell 3000® Index GlobeNewswire
Jun-13-18 07:00AM  Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018 GlobeNewswire
Jun-08-18 04:04PM  Edited Transcript of TTOO earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents +11.35%
Jun-06-18 10:08AM  Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2018 PR Newswire
07:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Jun-05-18 07:00AM  T2 Biosystems Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-03-18 10:00AM  How to Manage Risk in Biotech Stocks TheStreet.com
Jun-01-18 02:54PM  Here's Why T2 Biosystems, Inc. Rose Over 16% Today Motley Fool +10.53%
07:00AM  T2 Biosystems to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-31-18 07:00AM  T2 Biosystems Announces Pricing of Public Offering of Common Stock GlobeNewswire
May-30-18 08:14AM  Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA Benzinga
May-29-18 04:14PM  T2 Biosystems Announces Proposed Public Offering of Common Stock GlobeNewswire -9.13%
10:16AM  T2Biosystems Announces FDA Approval For Sepsis Test: 'This Is A Game-Changer' Benzinga
08:56AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:00AM  T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens GlobeNewswire
May-08-18 06:19PM  T2 Biosystems: 1Q Earnings Snapshot Associated Press
04:01PM  T2 Biosystems Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-03-18 08:00AM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Apr-30-18 08:00AM  T2 Biosystems Announces 2018 First Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Apr-20-18 10:17AM  Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) PR Newswire
Apr-04-18 04:05PM  T2 Biosystems Reports Granting of Inducement Awards GlobeNewswire
Mar-28-18 08:30AM  Multiple New Studies Demonstrate T2 Biosystems Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics GlobeNewswire
Mar-19-18 04:05PM  T2 Biosystems to Present at the 17th Annual Needham Healthcare Conference GlobeNewswire
Mar-09-18 02:16AM  Edited Transcript of TTOO earnings conference call or presentation 6-Mar-18 9:30pm GMT Thomson Reuters StreetEvents +6.58%
Mar-07-18 08:00AM  T2 Biosystems Reports Granting of Inducement Award GlobeNewswire -7.43%
Mar-06-18 04:00PM  T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update GlobeNewswire
12:15PM  T2 Biosystems, Inc. to Host Earnings Call ACCESSWIRE
11:55AM  Should T2 Biosystems Incs (NASDAQ:TTOO) Recent Earnings Decline Worry You? Simply Wall St.
07:00AM  T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria GlobeNewswire
Feb-20-18 08:00AM  T2 Biosystems Announces 2017 Fourth Quarter and Full-Year Financial and Operational Results Release and Conference Call Date GlobeNewswire
Feb-09-18 08:34AM  Two New Studies Demonstrate T2Candidas Advantages over Current Diagnostic Testing GlobeNewswire -5.73%
Feb-06-18 08:00AM  T2 Biosystems to Present at the 7th Annual Leerink Partners Global Healthcare Conference GlobeNewswire
Feb-05-18 04:30PM  T2 Biosystems Announces CFO Transition GlobeNewswire
Jan-12-18 12:20PM  Whats the Competitive Landscape for Accelerate Diagnostics? Market Realist
10:50AM  Whats the Potential Market for Accelerate Diagnostics Products? Market Realist
Jan-04-18 04:05PM  T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel GlobeNewswire
Dec-26-17 12:16PM  ETFs with exposure to T2 Biosystems, Inc. : December 26, 2017 Capital Cube
Nov-27-17 08:00AM  T2 Biosystems to Attend the Global Mizuho Investor Conference GlobeNewswire
Nov-20-17 09:26AM  T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017 GlobeNewswire
Nov-09-17 08:00AM  T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 GlobeNewswire
Nov-08-17 06:39PM  ETFs with exposure to T2 Biosystems, Inc. : November 8, 2017 Capital Cube
Nov-07-17 08:12AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-06-17 04:48PM  Edited Transcript of TTOO earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-02-17 06:54PM  T2 Biosystems reports 3Q loss Associated Press
04:05PM  T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update GlobeNewswire
11:30AM  T2 Biosystems, Inc. to Host Earnings Call ACCESSWIRE
Nov-01-17 08:01AM  T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum GlobeNewswire
Oct-16-17 08:00AM  T2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Oct-13-17 11:18AM  ETFs with exposure to T2 Biosystems, Inc. : October 13, 2017 Capital Cube
Oct-12-17 10:45AM  Clinicians Discuss Positive Impact of T2MR Platform on Sepsis Care at IDWeek 2017 GlobeNewswire
Oct-03-17 07:00AM  Study Published in Journal of Antimicrobial Stewardship Shows Patients Diagnosed with T2Candida Panel Treated More Than Eight Times Faster GlobeNewswire
Sep-21-17 08:00AM  T2 Biosystems Announces Presentations at IDWeek 2017 GlobeNewswire
Sep-19-17 09:35AM  5 Medtech Stocks to Steer Clear of Amid Political Chaos Zacks
Sep-18-17 08:00AM  T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-15-17 10:25AM  T2 Biosystems Prices Secondary Offering 24/7 Wall St. -25.66%
08:49AM  T2 Biosystems' stock sinks on heavy volume after share offering prices at deep discount MarketWatch
08:20AM  T2 Biosystems Announces Pricing of Public Offering of Common Stock GlobeNewswire
Sep-14-17 04:11PM  T2 Biosystems Announces Proposed Public Offering of Common Stock GlobeNewswire -10.32%
Sep-12-17 06:20PM  With FDA filing, Lexington firm targets a scourge of hospitals: sepsis American City Business Journals +8.29%
Sep-11-17 08:00AM  T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Bacteria Panel GlobeNewswire +9.49%
Sep-06-17 07:05AM  T2 Biosystems and Cidara Therapeutics Announce Partnership for Commercial Placement of T2Dx Instruments to Support CD101 Drug Trials GlobeNewswire
07:00AM  T2 Biosystems Announces Collaboration with CDC to Detect Emerging Superbug Candida auris GlobeNewswire
Aug-31-17 09:46PM  ETFs with exposure to T2 Biosystems, Inc. : September 1, 2017 Capital Cube
Aug-30-17 08:00AM  T2 Biosystems Announces 11 New Patents Granted in 2017 GlobeNewswire
Aug-24-17 11:24AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-15-17 10:18AM  T2 Biosystems and Aridis Pharmaceuticals, Inc. Join Antimicrobials Working Group PR Newswire +5.88%
Aug-11-17 11:51PM  Edited Transcript of TTOO earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents +6.51%
Aug-04-17 08:13PM  T2 Biosystems reports 2Q loss Associated Press +15.50%
Aug-03-17 04:05PM  T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update GlobeNewswire
12:10PM  Investor Network: T2 Biosystems, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 08:00AM  T2 Biosystems to Present at the 37th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-27-17 08:58AM  T2 Biosystems Joins Antimicrobials Working Group as First Diagnostic Member GlobeNewswire
Jul-20-17 08:00AM  T2 Biosystems Announces 2017 Second Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Jul-18-17 08:00AM  T2 BIOSYSTEMS RECEIVES CE MARK FOR T2BACTERIA PANEL ENABLING COMMERCIALIZATION IN EUROPE GlobeNewswire +12.41%
Jul-13-17 04:48PM  ETFs with exposure to T2 Biosystems, Inc. : July 13, 2017 Capital Cube
Jun-19-17 08:00AM  T2 Biosystems Chief Scientific Officer Tom Lowery to Present at BIO 2017 Convention GlobeNewswire
Jun-08-17 08:00AM  T2 Biosystems to Present at the 2017 Marcum Microcap Conference GlobeNewswire
Jun-07-17 08:00AM  T2 Biosystems Announces New T2Sepsis Solution Clinical and Economic Results Presented by Leading Experts at ASM Microbe 2017 Conference GlobeNewswire
Jun-01-17 10:00AM  Study Published in the Journal of Clinical Microbiology Highlights Detection of Lyme Disease-Causing Bactera in Blood Using T2 Biosystems T2MR® Technology GlobeNewswire +12.39%
May-30-17 08:00AM  T2 Biosystems to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-25-17 12:50PM  ETFs with exposure to T2 Biosystems, Inc. : May 25, 2017 Capital Cube
May-24-17 08:00AM  T2 Biosystems Announces Presentations at ASM Microbe 2017 Conference GlobeNewswire
May-19-17 07:30AM  Henry Ford Health System to Present Webinar on Positive Clinical Impact of T2 Biosystems T2Candida® Panel GlobeNewswire
May-11-17 05:39PM  ETFs with exposure to T2 Biosystems, Inc. : May 11, 2017 Capital Cube
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications, as well as T2Candida panel for the detection of candida species in human whole blood specimens. In addition, it is developing T2Bacteria, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2Lyme for the detection of various strains of Lyme disease-causing bacteria; and T2Plex, an integrated instrument for hemostasis applications. The company has collaboration agreement with Canon U.S. Life Sciences, Inc. to develop a novel diagnostic test panel to detect Lyme disease; and Allergan Sales, LLC for the direct detection diagnostic test panel that adds additional bacteria species to the existing T2Bacteria product candidate and testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lowery Thomas J.Chief Scientific OfficerSep 20Option Exercise3.2248,205155,22091,431Sep 21 04:00 PM
Lowery Thomas J.Chief Scientific OfficerSep 20Sale6.1848,205297,90743,226Sep 21 04:00 PM
Lowery Thomas J.Chief Scientific OfficerSep 19Option Exercise2.9537,902111,95481,128Sep 20 06:26 PM
Lowery Thomas J.Chief Scientific OfficerSep 19Sale6.2037,902234,99243,226Sep 20 06:26 PM
Lowery Thomas J.Chief Scientific OfficerSep 18Option Exercise1.90100,242190,824143,468Sep 20 06:26 PM
Lowery Thomas J.Chief Scientific OfficerSep 18Sale6.17100,242618,05443,226Sep 20 06:26 PM
Lowery Thomas J.Chief Scientific OfficerJun 28Option Exercise0.0026,847051,947Jun 29 02:39 PM
McDonough JohnPresident and CEOJun 28Option Exercise0.00108,6960393,909Jun 29 02:38 PM
Sprague John MChief Financial OfficerJun 28Option Exercise0.0017,292017,292Jun 29 02:39 PM
Gibbs Michael TerrenceGeneral CounselJun 28Option Exercise0.0024,086050,791Jun 29 02:42 PM
Barclay AlecSee RemarksJun 28Option Exercise0.0024,086034,979Jun 29 02:40 PM
Lapidus StanleyDirectorJun 05Sale8.876,00053,22032,000Jun 05 04:42 PM
Elsbree David BDirectorJun 01Buy7.654,22532,32110,000Jun 05 04:48 PM
Lowery Thomas J.Chief Scientific OfficerFeb 09Sale4.282,2029,42514,042Jun 08 03:51 PM
Gibbs Michael TerrenceGeneral CounselFeb 09Sale4.282,2029,42516,911Jun 08 03:52 PM
McDonough JohnPresident & CEOFeb 09Sale4.286,29226,930262,834Jun 08 03:53 PM
Elsbree David BDirectorNov 16Buy4.111,5006,1655,775Nov 17 02:33 PM